|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/00 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3880186 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19817846.9 |
| Date of filing the European patent application | 2019-11-13 | |
| (97) | Date of publication of the European application | 2021-09-22 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-03 |
| (46) | Date of publication of the claims translation | 2024-06-10 |
| (86) | Number | PCT/US2019/061212 |
| Date | 2019-11-13 |
| (87) | Number | WO 2020/102375 |
| Date | 2020-05-22 |
| (30) | Number | Date | Country code |
| 201862767218 P | 2018-11-14 | US |
| (72) |
FURY, Matthew G. , US
LOWY, Israel , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6706,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | PD-1 inhibitorių skyrimas į pažeidimo vietą odos vėžiui gydyti |
| INTRALESIONAL ADMINISTRATION OF PD-1 INHIBITORS FOR TREATING SKIN CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 7 | 162.00 EUR |
| 2026-11-13 |